Top

Clinical Oral Investigations

Published in:

01-03-2015 | Original Article

A chemiluminescent light system in combination with toluidine blue to assess suspicious oral lesions—clinical evaluation and review of the literature

Authors: P. W. Kämmerer, R. K. Rahimi-Nedjat, T. Ziebart, A. Bemsch, C. Walter, B. Al-Nawas, F. P. Koch

Published in: Clinical Oral Investigations | Issue 2/2015

Abstract

Objectives

The aim of the study was an evaluation of an acetic acid wash and chemiluminescent light system in combination with toluidine blue in order to detect visual identified, potentially malignant lesions.

Materials and methods

Forty-four patients with 50 oral lesions of primary uncertain visible dignity were included. Next to a clinical examination, a screening with ViziLite® (VL) as well as toluidine blue (TB; together ViziLite® Plus (VLP)) was conducted. Histopathology served as gold standard and sensitivity (SE), specificity (SP), positive as well as negative predictive value (PPV, NPV) was calculated descriptively. Additionally, a PubMed literature search using the key words “ViziLite” and “chemiluminescence oral cancer” was conducted.

Results

Histological diagnosis showed 40 lesions of reactive/inflammatory nature, moderate dysplasia (n = 3) and oral squamous cell carcinoma (OSCC n = 7). All OSCCs and one dysplasia were identified correct via clinical diagnosis (SE 90 %, SP 100 %, PPV 100 %, NPV 97.5 %). VL examination could show all malignancies with low specificity (SE 100 %, SP 30 %, PPV 26 %, NPV 100 %). TB and VLP were positive in all cases of cancer and in one case of inflammation (SE 80 %, SP 97.5 %, PPV 89 %, NPV 95 %). In the review, eight clinical trials with similar results were included.

Conclusions

The adjunct of TB to VL reduces the number of false positives without increasing the rate of false negatives.

Clinical relevance

Clinical evidence to justify the additional cost of the system for diagnosis of suspicious lesions is weak. However, for the potential role of VLP in detection of lesions not otherwise identified in the visual exam in general dental practice further studies are required.

Robinson PN, Mickelson AR (2006) Early diagnosis of oral cavity cancers. Otolaryngol Clin N Am 39:295–306CrossRef

Sciubba JJ (2000) Oral precancer and cancer: etiology, clinical presentation, diagnosis, and management. Compend Contin Educ Dent 21(892–898):900–902

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225–249CrossRefPubMed

Mehrotra R, Singh M, Thomas S, Nair P, Pandya S, Nigam NS, Shukla P (2010) A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc 141:151–156CrossRefPubMed

Downer MC, Moles DR, Palmer S, Speight PM (2004) A systematic review of test performance in screening for oral cancer and precancer. Oral Oncol 40:264–273CrossRefPubMed

Shin D, Vigneswaran N, Gillenwater A, Richards-Kortum R (2010) Advances in fluorescence imaging techniques to detect oral cancer and its precursors. Future Oncol 6:1143–1154CrossRefPubMedCentralPubMed

Zadik Y, Orbach H, Panzok A, Smith Y, Czerninski R (2012) Evaluation of oral mucosal diseases: inter- and intra-observer analyses. J Oral Pathol Med 41:68–72CrossRefPubMed

Koch FP, Kunkel M, Biesterfeld S, Wagner W (2011) Diagnostic efficiency of differentiating small cancerous and precancerous lesions using mucosal brush smears of the oral cavity—a prospective and blinded study. Clin Oral Investig 15:763–769CrossRefPubMed

Kämmerer PW, Klein MO, Moergel M, Gemmel M, Draenert GF (2013) Local and systemic risk factors influencing the long-term success of angular stable alloplastic reconstruction plates of the mandible. J Craniomaxillofac Surg [Epub ahead of print]

10.

Macaulay C, Poh CF, Guillaud M, Michele Williams P, Laronde DM, Zhang L, Rosin MP (2012) High throughput image cytometry for detection of suspicious lesions in the oral cavity. J Biomed Opt 17:086004–086001CrossRefPubMed

11.

Toyoshima T, Koch F, Kaemmerer P, Vairaktaris E, Al-Nawas B, Wagner W (2009) Expression of cytokeratin 17 mRNA in oral squamous cell carcinoma cells obtained by brush biopsy: preliminary results. J Oral Pathol Med 38:530–534CrossRefPubMed

12.

Driemel O, Dahse R, Hakim SG, Tsioutsias T, Pistner H, Reichert TE, Kosmehl H (2007) Laminin-5 immunocytochemistry: a new tool for identifying dysplastic cells in oral brush biopsies. Cytopathology 18:348–355CrossRefPubMed

13.

Zhang L, Rosin MP (2001) Loss of heterozygosity: a potential tool in management of oral premalignant lesions? J Oral Pathol Med 30:513–520CrossRefPubMed

14.

Watanabe A, Taniguchi M, Tsujie H, Hosokawa M, Fujita M, Sasaki S (2012) Clinical impact of iodine staining for diagnosis of carcinoma in situ in the floor of mouth, and decision of adequate surgical margin. Auris Nasus Larynx 39:193–197CrossRefPubMed

15.

Cancela-Rodriguez P, Cerero-Lapiedra R, Esparza-Gomez G, Llamas-Martinez S, Warnakulasuriya S (2011) The use of toluidine blue in the detection of pre-malignant and malignant oral lesions. J Oral Pathol Med 40:300–304CrossRefPubMed

16.

Koch FP, Kaemmerer PW, Biesterfeld S, Kunkel M, Wagner W (2011) Effectiveness of autofluorescence to identify suspicious oral lesions—a prospective, blinded clinical trial. Clin Oral Investig 15:975–982CrossRefPubMed

17.

Awan KH, Morgan PR, Warnakulasuriya S (2011) Evaluation of an autofluorescence based imaging system (VELscope) in the detection of oral potentially malignant disorders and benign keratoses. Oral Oncol 47:274–277CrossRefPubMed

18.

Brocklehurst P, Kujan O, Glenny AM, Oliver R, Sloan P, Ogden G, Shepherd S (2010) Screening programmes for the early detection and prevention of oral cancer. Cochrane Database Syst Rev 10:CD004150

19.

Lonky NM, Mann WJ, Massad LS, Mutch DG, Blanco JS, Vasilev SA, Finan MA, Scotti RJ (1995) Ability of visual tests to predict underlying cervical neoplasia. Colposcopy and speculoscopy. J Reprod Med 40:530–536PubMed

20.

Epstein JB, Oakley C, Millner A, Emerton S, van der Meij E, Le N (1997) The utility of toluidine blue application as a diagnostic aid in patients previously treated for upper oropharyngeal carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 83:537–547CrossRefPubMed

21.

Epstein JB, Silverman S Jr, Epstein JD, Lonky SA, Bride MA (2008) Analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue. Oral Oncol 44:538–544CrossRefPubMed

22.

Rajmohan M, Rao UK, Joshua E, Rajasekaran ST, Kannan R (2012) Assessment of oral mucosa in normal, precancer and cancer using chemiluminescent illumination, toluidine blue supravital staining and oral exfoliative cytology. J Oral Maxillofac Pathol 16:325–329CrossRefPubMedCentralPubMed

23.

Mojsa I, Kaczmarzyk T, Zaleska M, Stypulkowska J, Zapala-Pospiech A, Sadecki D (2012) Value of the ViziLite Plus System as a diagnostic aid in the early detection of oral cancer/premalignant epithelial lesions. J Craniofac Surg 23:e162–e164CrossRefPubMed

24.

Ujaoney S, Motwani MB, Degwekar S, Wadhwan V, Zade P, Chaudhary M, Hazarey V, Thakre TP, Mamtani M (2012) Evaluation of chemiluminescence, toluidine blue and histopathology for detection of high risk oral precancerous lesions: a cross-sectional study. BMC Clin Pathol 12:6CrossRefPubMedCentralPubMed

25.

Patton LL, Epstein JB, Kerr AR (2008) Adjunctive techniques for oral cancer examination and lesion diagnosis: a systematic review of the literature. J Am Dent Assoc 139:896–905CrossRefPubMed

26.

Slater LJ (2009) Comment on "analysis of oral lesion biopsies identified and evaluated by visual examination, chemiluminescence and toluidine blue" [Epstein JB et al., Oral Oncol 2008;44(6):538–44]. Oral Oncol 45:296

27.

Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P (2006) Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation. Oral Oncol 42:987–993CrossRefPubMed

28.

Ram S, Siar CH (2005) Chemiluminescence as a diagnostic aid in the detection of oral cancer and potentially malignant epithelial lesions. Int J Oral Maxillofac Surg 34:521–527CrossRefPubMed

29.

Oh ES, Laskin DM (2007) Efficacy of the ViziLite system in the identification of oral lesions. J Oral Maxillofac Surg 65:424–426CrossRefPubMed

30.

Epstein JB, Gorsky M, Lonky S, Silverman S Jr, Epstein JD, Bride M (2006) The efficacy of oral lumenoscopy (ViziLite) in visualizing oral mucosal lesions. Spec Care Dent 26:171–174CrossRef

31.

Kerr AR, Sirois DA, Epstein JB (2006) Clinical evaluation of chemiluminescent lighting: an adjunct for oral mucosal examinations. J Clin Dent 17:59–63PubMed

32.

Huber MA, Bsoul SA, Terezhalmy GT (2004) Acetic acid wash and chemiluminescent illumination as an adjunct to conventional oral soft tissue examination for the detection of dysplasia: a pilot study. Quintessence Int 35:378–384PubMed

33.

Awan KH, Morgan PR, Warnakulasuriya S (2011) Utility of chemiluminescence (ViziLite) in the detection of oral potentially malignant disorders and benign keratoses. J Oral Pathol Med 40:541–544CrossRefPubMed

34.

Farah CS, McCullough MJ (2007) A pilot case control study on the efficacy of acetic acid wash and chemiluminescent illumination (ViziLite) in the visualisation of oral mucosal white lesions. Oral Oncol 43:820–804CrossRefPubMed

35.

Rethman MP, Carpenter W, Cohen EE, Epstein J, Evans CA, Flaitz CM, Graham FJ, Hujoel PP, Kalmar JR, Koch WM, Lambert PM, Lingen MW, Oettmeier BW Jr, Patton LL, Perkins D, Reid BC, Sciubba JJ, Tomar SL, Wyatt AD Jr, Aravamudhan K, Frantsve-Hawley J, Cleveland JL, Meyer DM (2010) Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas. J Am Dent Assoc 141:509–520CrossRefPubMed

36.

Rosenberg D, Cretin S (1989) Use of meta-analysis to evaluate tolonium chloride in oral cancer screening. Oral Surg Oral Med Oral Pathol 67:621–627CrossRefPubMed

37.

Niebel HH, Chomet B (1964) In vivo staining test for delineation of oral intraepithelial neoplastic change: preliminary report. J Am Dent Assoc 68:801–806CrossRefPubMed

38.

Martin IC, Kerawala CJ, Reed M (1998) The application of toluidine blue as a diagnostic adjunct in the detection of epithelial dysplasia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85:444–446CrossRefPubMed

39.

Guneri P, Epstein JB, Ergun S, Boyacioglu H (2011) Toluidine blue color perception in identification of oral mucosal lesions. Clin Oral Investig 15:337–345CrossRefPubMed

Title: A chemiluminescent light system in combination with toluidine blue to assess suspicious oral lesions—clinical evaluation and review of the literature
Authors: P. W. Kämmerer
R. K. Rahimi-Nedjat
T. Ziebart
A. Bemsch
C. Walter
B. Al-Nawas
F. P. Koch
Publication date: 01-03-2015
Publisher: Springer Berlin Heidelberg
Published in: Clinical Oral Investigations / Issue 2/2015
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-014-1252-z

At a glance: The STEP trials

Springer Medicine

A chemiluminescent light system in combination with toluidine blue to assess suspicious oral lesions—clinical evaluation and review of the literature

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

At a glance: The STEP trials

Springer Medicine

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Please log in to get access to this content

Other articles of this Issue 2/2015

Comparison of Forsus FRD EZ and Andresen activator in the treatment of class II, division 1 malocclusions

Effect of oral appliance on endothelial function in sleep apnea

A micro-computed tomography study of the relationship between radicular grooves and root canal morphology in mandibular first premolars

Oral surgery during therapy with anticoagulants—a systematic review

Fractal analysis for the assessment of trabecular peri-implant alveolar bone using panoramic radiographs

Fracture behavior of metal-ceramic fixed dental prostheses with frameworks from cast or a newly developed sintered cobalt-chromium alloy